[
  {
    "title": "Regeneron Announces Investor Conference Presentations",
    "published": 1715025900,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 958.0,
      "2024-05-06T14:30:00+00:00": 953.3250122070312,
      "2024-05-06T15:30:00+00:00": 955.3200073242188,
      "2024-05-06T16:30:00+00:00": 953.1300048828125,
      "2024-05-06T17:30:00+00:00": 955.8900146484375,
      "2024-05-06T18:30:00+00:00": 956.260009765625,
      "2024-05-06T19:30:00+00:00": 955.739990234375
    },
    "sentiment": 0.9291732907295227
  },
  {
    "title": "Why Investors Are Eyeing Regeneron Pharmaceuticals Inc (REGN): The Key Drivers of Market ...",
    "published": 1714989720,
    "day_prices": {
      "2024-05-06T13:30:00+00:00": 958.0,
      "2024-05-06T14:30:00+00:00": 953.3250122070312,
      "2024-05-06T15:30:00+00:00": 955.3200073242188,
      "2024-05-06T16:30:00+00:00": 953.1300048828125,
      "2024-05-06T17:30:00+00:00": 955.8900146484375,
      "2024-05-06T18:30:00+00:00": 956.260009765625,
      "2024-05-06T19:30:00+00:00": 955.739990234375
    },
    "sentiment": 0.9107043743133545
  },
  {
    "title": "3 Biotech Stocks With the Potential to Make You an Overnight Millionaire",
    "published": 1714838400,
    "day_prices": {},
    "sentiment": 0.8275285959243774
  },
  {
    "title": "Amgen Could Become A Real Contender In The Obesity Market",
    "published": 1714813982,
    "day_prices": {},
    "sentiment": 0.5144065618515015
  },
  {
    "title": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript",
    "published": 1714745746,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 926.9400024414062,
      "2024-05-03T14:30:00+00:00": 941.02001953125,
      "2024-05-03T15:30:00+00:00": 941.0999755859375,
      "2024-05-03T16:30:00+00:00": 943.9099731445312,
      "2024-05-03T17:30:00+00:00": 946.6300048828125,
      "2024-05-03T18:30:00+00:00": 951.2100219726562,
      "2024-05-03T19:30:00+00:00": 953.8099975585938
    },
    "sentiment": 0.9181250929832458
  },
  {
    "title": "Assessing Regeneron Pharmaceuticals: Insights From 16 Financial Analysts",
    "published": 1714734000,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 926.9400024414062,
      "2024-05-03T14:30:00+00:00": 941.02001953125,
      "2024-05-03T15:30:00+00:00": 941.0999755859375,
      "2024-05-03T16:30:00+00:00": 943.9099731445312,
      "2024-05-03T17:30:00+00:00": 946.6300048828125,
      "2024-05-03T18:30:00+00:00": 951.2100219726562,
      "2024-05-03T19:30:00+00:00": 953.8099975585938
    },
    "sentiment": 0.8024248480796814
  },
  {
    "title": "Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...",
    "published": 1714720235,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 926.9400024414062,
      "2024-05-03T14:30:00+00:00": 941.02001953125,
      "2024-05-03T15:30:00+00:00": 941.0999755859375,
      "2024-05-03T16:30:00+00:00": 943.9099731445312,
      "2024-05-03T17:30:00+00:00": 946.6300048828125,
      "2024-05-03T18:30:00+00:00": 951.2100219726562,
      "2024-05-03T19:30:00+00:00": 953.8099975585938
    },
    "sentiment": 0.8544153571128845
  },
  {
    "title": "Truist Financial Keeps Their Buy Rating on Regeneron (REGN)",
    "published": 1714717860,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 926.9400024414062,
      "2024-05-03T14:30:00+00:00": 941.02001953125,
      "2024-05-03T15:30:00+00:00": 941.0999755859375,
      "2024-05-03T16:30:00+00:00": 943.9099731445312,
      "2024-05-03T17:30:00+00:00": 946.6300048828125,
      "2024-05-03T18:30:00+00:00": 951.2100219726562,
      "2024-05-03T19:30:00+00:00": 953.8099975585938
    },
    "sentiment": 0.8969982862472534
  },
  {
    "title": "Buy Rating Affirmed: Regeneron\u2019s Promising Pipeline and Potential for Surpassing Earnings Expectations",
    "published": 1714714620,
    "day_prices": {
      "2024-05-03T13:30:00+00:00": 926.9400024414062,
      "2024-05-03T14:30:00+00:00": 941.02001953125,
      "2024-05-03T15:30:00+00:00": 941.0999755859375,
      "2024-05-03T16:30:00+00:00": 943.9099731445312,
      "2024-05-03T17:30:00+00:00": 946.6300048828125,
      "2024-05-03T18:30:00+00:00": 951.2100219726562,
      "2024-05-03T19:30:00+00:00": 953.8099975585938
    },
    "sentiment": 0.9544216990470886
  },
  {
    "title": "Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales",
    "published": 1714658460,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.9209335446357727
  },
  {
    "title": "Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ...",
    "published": 1714653178,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.5983364582061768
  },
  {
    "title": "Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?",
    "published": 1714651222,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.9447453022003174
  },
  {
    "title": "Regeneron Reports First Quarter 2024 Financial and Operating Results",
    "published": 1714645800,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.49029096961021423
  },
  {
    "title": "REGN Stock Earnings: Regeneron Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024",
    "published": 1714643700,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.9565255045890808
  },
  {
    "title": "Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years",
    "published": 1714642560,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.9336328506469727
  },
  {
    "title": "Regeneron says FDA requested additional analyses during Dupixent sBLA review",
    "published": 1714637220,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.8890453577041626
  },
  {
    "title": "Regeneron: Adjusted EPS down 4% in Q1",
    "published": 1714634606,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.9743160605430603
  },
  {
    "title": "Regeneron falls after Q1 miss; announces $3B share buybacks",
    "published": 1714633020,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.9192521572113037
  },
  {
    "title": "Regeneron misses profit estimates on weaker Eylea and Dupixent sales",
    "published": 1714631673,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.967100203037262
  },
  {
    "title": "Regeneron Pharmaceuticals misses top-line and bottom-line estimates; updates FY24 outlook",
    "published": 1714628040,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.804728627204895
  },
  {
    "title": "Regeneron announces new $3B share repurchase program",
    "published": 1714627980,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.7082762122154236
  },
  {
    "title": "Regeneron's stock jumps 4% as analysts look to pipeline",
    "published": 1714618972,
    "day_prices": {
      "2024-05-02T13:30:00+00:00": 900.0,
      "2024-05-02T14:30:00+00:00": 916.5999755859375,
      "2024-05-02T15:30:00+00:00": 924.989990234375,
      "2024-05-02T16:30:00+00:00": 937.5650024414062,
      "2024-05-02T17:30:00+00:00": 943.4099731445312,
      "2024-05-02T18:30:00+00:00": 934.3350219726562,
      "2024-05-02T19:30:00+00:00": 938.5800170898438
    },
    "sentiment": 0.9090224504470825
  },
  {
    "title": "Adverum Biotechnologies a new buy at H.C. Wainwright on wet AMD gene therapy",
    "published": 1714566060,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 889.0599975585938,
      "2024-05-01T14:30:00+00:00": 892.5032958984375,
      "2024-05-01T15:30:00+00:00": 899.385009765625,
      "2024-05-01T16:30:00+00:00": 899.6500244140625,
      "2024-05-01T17:30:00+00:00": 898.530029296875,
      "2024-05-01T18:30:00+00:00": 903.2000122070312,
      "2024-05-01T19:30:00+00:00": 912.14501953125
    },
    "sentiment": 0.5101462602615356
  },
  {
    "title": "Regeneron Pharmaceuticals Q1 2024 Earnings Preview",
    "published": 1714559820,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 889.0599975585938,
      "2024-05-01T14:30:00+00:00": 892.5032958984375,
      "2024-05-01T15:30:00+00:00": 899.385009765625,
      "2024-05-01T16:30:00+00:00": 899.6500244140625,
      "2024-05-01T17:30:00+00:00": 898.530029296875,
      "2024-05-01T18:30:00+00:00": 903.2000122070312,
      "2024-05-01T19:30:00+00:00": 912.14501953125
    },
    "sentiment": 0.8994348645210266
  },
  {
    "title": "Regeneron sees FY24 adjusted EPS $1.42-$1.49, consensus $1.46",
    "published": 1714545240,
    "day_prices": {
      "2024-05-01T13:30:00+00:00": 889.0599975585938,
      "2024-05-01T14:30:00+00:00": 892.5032958984375,
      "2024-05-01T15:30:00+00:00": 899.385009765625,
      "2024-05-01T16:30:00+00:00": 899.6500244140625,
      "2024-05-01T17:30:00+00:00": 898.530029296875,
      "2024-05-01T18:30:00+00:00": 903.2000122070312,
      "2024-05-01T19:30:00+00:00": 912.14501953125
    },
    "sentiment": 0.5758772492408752
  },
  {
    "title": "Regeneron Pharmaceuticals Inc (REGN) RBC Capital Markets Global Healthcare Conference (Transcript)",
    "published": 1715690529,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 980.0,
      "2024-05-14T14:30:00+00:00": 976.47998046875,
      "2024-05-14T15:30:00+00:00": 977.5499877929688,
      "2024-05-14T16:30:00+00:00": 978.625,
      "2024-05-14T17:30:00+00:00": 978.7050170898438,
      "2024-05-14T18:30:00+00:00": 984.0,
      "2024-05-14T19:30:00+00:00": 986.5499877929688
    },
    "sentiment": 0.9251840710639954
  },
  {
    "title": "Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 10 Years",
    "published": 1715679360,
    "day_prices": {
      "2024-05-14T13:30:00+00:00": 980.0,
      "2024-05-14T14:30:00+00:00": 976.47998046875,
      "2024-05-14T15:30:00+00:00": 977.5499877929688,
      "2024-05-14T16:30:00+00:00": 978.625,
      "2024-05-14T17:30:00+00:00": 978.7050170898438,
      "2024-05-14T18:30:00+00:00": 984.0,
      "2024-05-14T19:30:00+00:00": 986.5499877929688
    },
    "sentiment": 0.934251606464386
  },
  {
    "title": "Dupixent set for FDA review in adolescent chronic inflammatory sinus disease",
    "published": 1715612536,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 980.0,
      "2024-05-13T14:30:00+00:00": 977.4149780273438,
      "2024-05-13T15:30:00+00:00": 977.989990234375,
      "2024-05-13T16:30:00+00:00": 973.2449951171875,
      "2024-05-13T17:30:00+00:00": 974.489990234375,
      "2024-05-13T18:30:00+00:00": 976.9400024414062,
      "2024-05-13T19:30:00+00:00": 975.489990234375
    },
    "sentiment": 0.8244390487670898
  },
  {
    "title": "Regeneron gets FDA priority review for airway disease drug",
    "published": 1715580540,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 980.0,
      "2024-05-13T14:30:00+00:00": 977.4149780273438,
      "2024-05-13T15:30:00+00:00": 977.989990234375,
      "2024-05-13T16:30:00+00:00": 973.2449951171875,
      "2024-05-13T17:30:00+00:00": 974.489990234375,
      "2024-05-13T18:30:00+00:00": 976.9400024414062,
      "2024-05-13T19:30:00+00:00": 975.489990234375
    },
    "sentiment": 0.6390403509140015
  },
  {
    "title": "Regeneron, Sanofi announce FDA acceptance for priority review of Dupixent sBLA",
    "published": 1715574480,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 980.0,
      "2024-05-13T14:30:00+00:00": 977.4149780273438,
      "2024-05-13T15:30:00+00:00": 977.989990234375,
      "2024-05-13T16:30:00+00:00": 973.2449951171875,
      "2024-05-13T17:30:00+00:00": 974.489990234375,
      "2024-05-13T18:30:00+00:00": 976.9400024414062,
      "2024-05-13T19:30:00+00:00": 975.489990234375
    },
    "sentiment": 0.7778149247169495
  },
  {
    "title": "Regeneron initiated with bullish view at Evercore ISI, here's why",
    "published": 1715569860,
    "day_prices": {
      "2024-05-13T13:30:00+00:00": 980.0,
      "2024-05-13T14:30:00+00:00": 977.4149780273438,
      "2024-05-13T15:30:00+00:00": 977.989990234375,
      "2024-05-13T16:30:00+00:00": 973.2449951171875,
      "2024-05-13T17:30:00+00:00": 974.489990234375,
      "2024-05-13T18:30:00+00:00": 976.9400024414062,
      "2024-05-13T19:30:00+00:00": 975.489990234375
    },
    "sentiment": 0.7669188380241394
  },
  {
    "title": "Q1 2024 Intellia Therapeutics Inc Earnings Call",
    "published": 1715313196,
    "day_prices": {
      "2024-05-10T13:30:00+00:00": 970.0,
      "2024-05-10T14:30:00+00:00": 976.7000122070312,
      "2024-05-10T15:30:00+00:00": 972.4199829101562,
      "2024-05-10T16:30:00+00:00": 975.5900268554688,
      "2024-05-10T17:30:00+00:00": 975.7899780273438,
      "2024-05-10T18:30:00+00:00": 975.3099975585938,
      "2024-05-10T19:30:00+00:00": 976.0
    },
    "sentiment": 0.7336507439613342
  },
  {
    "title": "REGENERON PHARMACEUTICALS - LATEST DB-OTO RESULTS SHOW DRAMATICALLY IMPROVED HEARING TO NORMAL LEVELS IN A CHILD WITH PROFOUND GENETIC DEAFNESS WITHIN 24 WEEKS AND INITIAL HEARING IMPROVEMENTS IN A SECOND CHILD AT 6 WEEKS",
    "published": 1715248729,
    "day_prices": {
      "2024-05-09T13:30:00+00:00": 959.5900268554688,
      "2024-05-09T14:30:00+00:00": 964.1099853515625,
      "2024-05-09T15:30:00+00:00": 963.010009765625,
      "2024-05-09T16:30:00+00:00": 965.8599853515625,
      "2024-05-09T17:30:00+00:00": 968.9600219726562,
      "2024-05-09T18:30:00+00:00": 968.7000122070312,
      "2024-05-09T19:30:00+00:00": 968.47998046875
    },
    "sentiment": 0.9506378173828125
  },
  {
    "title": "Regeneron gene therapy improves hearing in two children",
    "published": 1715167800,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 969.9000244140625,
      "2024-05-08T14:30:00+00:00": 963.2999877929688,
      "2024-05-08T15:30:00+00:00": 959.10498046875,
      "2024-05-08T16:30:00+00:00": 958.52001953125,
      "2024-05-08T17:30:00+00:00": 956.280029296875,
      "2024-05-08T18:30:00+00:00": 954.0499877929688,
      "2024-05-08T19:30:00+00:00": 955.010009765625
    },
    "sentiment": 0.8213396668434143
  },
  {
    "title": "Regeneron gene therapy improves hearing in child deafness",
    "published": 1715152980,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 969.9000244140625,
      "2024-05-08T14:30:00+00:00": 963.2999877929688,
      "2024-05-08T15:30:00+00:00": 959.10498046875,
      "2024-05-08T16:30:00+00:00": 958.52001953125,
      "2024-05-08T17:30:00+00:00": 956.280029296875,
      "2024-05-08T18:30:00+00:00": 954.0499877929688,
      "2024-05-08T19:30:00+00:00": 955.010009765625
    },
    "sentiment": 0.7321152687072754
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF), Tilray (TLRY) and Regeneron (REGN)",
    "published": 1715131920,
    "day_prices": {
      "2024-05-08T13:30:00+00:00": 969.9000244140625,
      "2024-05-08T14:30:00+00:00": 963.2999877929688,
      "2024-05-08T15:30:00+00:00": 959.10498046875,
      "2024-05-08T16:30:00+00:00": 958.52001953125,
      "2024-05-08T17:30:00+00:00": 956.280029296875,
      "2024-05-08T18:30:00+00:00": 954.0499877929688,
      "2024-05-08T19:30:00+00:00": 955.010009765625
    },
    "sentiment": 0.9038944840431213
  },
  {
    "title": "Verona Pharma: Key Inflection Point Directly Ahead",
    "published": 1716470612,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 985.4299926757812,
      "2024-05-23T14:30:00+00:00": 987.7550048828125,
      "2024-05-23T15:30:00+00:00": 990.52001953125,
      "2024-05-23T16:30:00+00:00": 990.52001953125,
      "2024-05-23T17:30:00+00:00": 985.22998046875,
      "2024-05-23T18:30:00+00:00": 984.8900146484375,
      "2024-05-23T19:30:00+00:00": 981.469970703125
    },
    "sentiment": 0.914091944694519
  },
  {
    "title": "3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years",
    "published": 1716459300,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 985.4299926757812,
      "2024-05-23T14:30:00+00:00": 987.7550048828125,
      "2024-05-23T15:30:00+00:00": 990.52001953125,
      "2024-05-23T16:30:00+00:00": 990.52001953125,
      "2024-05-23T17:30:00+00:00": 985.22998046875,
      "2024-05-23T18:30:00+00:00": 984.8900146484375,
      "2024-05-23T19:30:00+00:00": 981.469970703125
    },
    "sentiment": 0.839348554611206
  },
  {
    "title": "Regeneron reports 'positive' results from REGN7075 Phase 2 trial",
    "published": 1716437100,
    "day_prices": {
      "2024-05-23T13:30:00+00:00": 985.4299926757812,
      "2024-05-23T14:30:00+00:00": 987.7550048828125,
      "2024-05-23T15:30:00+00:00": 990.52001953125,
      "2024-05-23T16:30:00+00:00": 990.52001953125,
      "2024-05-23T17:30:00+00:00": 985.22998046875,
      "2024-05-23T18:30:00+00:00": 984.8900146484375,
      "2024-05-23T19:30:00+00:00": 981.469970703125
    },
    "sentiment": 0.9451427459716797
  },
  {
    "title": "Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Trading At A 48% Discount?",
    "published": 1716386426,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 993.0,
      "2024-05-22T14:30:00+00:00": 994.7255859375,
      "2024-05-22T15:30:00+00:00": 989.52001953125,
      "2024-05-22T16:30:00+00:00": 990.375,
      "2024-05-22T17:30:00+00:00": 992.010009765625,
      "2024-05-22T18:30:00+00:00": 986.6500244140625,
      "2024-05-22T19:30:00+00:00": 986.010009765625
    },
    "sentiment": 0.9286871552467346
  },
  {
    "title": "Wells Fargo Remains a Buy on Regeneron (REGN)",
    "published": 1716351420,
    "day_prices": {
      "2024-05-22T13:30:00+00:00": 993.0,
      "2024-05-22T14:30:00+00:00": 994.7255859375,
      "2024-05-22T15:30:00+00:00": 989.52001953125,
      "2024-05-22T16:30:00+00:00": 990.375,
      "2024-05-22T17:30:00+00:00": 992.010009765625,
      "2024-05-22T18:30:00+00:00": 986.6500244140625,
      "2024-05-22T19:30:00+00:00": 986.010009765625
    },
    "sentiment": 0.9380198121070862
  },
  {
    "title": "Analysts Are Bullish on Top Healthcare Stocks: Progyny (PGNY), Regeneron (REGN)",
    "published": 1716275520,
    "day_prices": {
      "2024-05-21T13:30:00+00:00": 987.989990234375,
      "2024-05-21T14:30:00+00:00": 995.1649780273438,
      "2024-05-21T15:30:00+00:00": 993.0,
      "2024-05-21T16:30:00+00:00": 992.125,
      "2024-05-21T17:30:00+00:00": 988.75,
      "2024-05-21T18:30:00+00:00": 993.0,
      "2024-05-21T19:30:00+00:00": 993.1799926757812
    },
    "sentiment": 0.6691092848777771
  },
  {
    "title": "7 Biotech Stocks That Could Breathe New Life Into Your Portfolio",
    "published": 1716226476,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 980.4199829101562,
      "2024-05-20T14:30:00+00:00": 982.6699829101562,
      "2024-05-20T15:30:00+00:00": 981.2899780273438,
      "2024-05-20T16:30:00+00:00": 980.64501953125,
      "2024-05-20T17:30:00+00:00": 982.9400024414062,
      "2024-05-20T18:30:00+00:00": 983.2100219726562,
      "2024-05-20T19:30:00+00:00": 985.1199951171875
    },
    "sentiment": 0.8768113255500793
  },
  {
    "title": "Large Cap Biopharmaceuticals Performance",
    "published": 1716209940,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 980.4199829101562,
      "2024-05-20T14:30:00+00:00": 982.6699829101562,
      "2024-05-20T15:30:00+00:00": 981.2899780273438,
      "2024-05-20T16:30:00+00:00": 980.64501953125,
      "2024-05-20T17:30:00+00:00": 982.9400024414062,
      "2024-05-20T18:30:00+00:00": 983.2100219726562,
      "2024-05-20T19:30:00+00:00": 985.1199951171875
    },
    "sentiment": 0.8903297781944275
  },
  {
    "title": "More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024",
    "published": 1716199949,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 980.4199829101562,
      "2024-05-20T14:30:00+00:00": 982.6699829101562,
      "2024-05-20T15:30:00+00:00": 981.2899780273438,
      "2024-05-20T16:30:00+00:00": 980.64501953125,
      "2024-05-20T17:30:00+00:00": 982.9400024414062,
      "2024-05-20T18:30:00+00:00": 983.2100219726562,
      "2024-05-20T19:30:00+00:00": 985.1199951171875
    },
    "sentiment": 0.9084648489952087
  },
  {
    "title": "(REGN) - Analyzing Regeneron Pharmaceuticals's Short Interest",
    "published": 1716171720,
    "day_prices": {
      "2024-05-20T13:30:00+00:00": 980.4199829101562,
      "2024-05-20T14:30:00+00:00": 982.6699829101562,
      "2024-05-20T15:30:00+00:00": 981.2899780273438,
      "2024-05-20T16:30:00+00:00": 980.64501953125,
      "2024-05-20T17:30:00+00:00": 982.9400024414062,
      "2024-05-20T18:30:00+00:00": 983.2100219726562,
      "2024-05-20T19:30:00+00:00": 985.1199951171875
    },
    "sentiment": 0.9037452936172485
  },
  {
    "title": "Roche Is Joining The Obesity Party But Questions Remain",
    "published": 1716031133,
    "day_prices": {},
    "sentiment": 0.9248262643814087
  },
  {
    "title": "Regeneron wins temporary restraining order preventing Eylea generic launch",
    "published": 1715936880,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 969.27001953125,
      "2024-05-17T14:30:00+00:00": 972.8300170898438,
      "2024-05-17T15:30:00+00:00": 976.0499877929688,
      "2024-05-17T16:30:00+00:00": 978.1199951171875,
      "2024-05-17T17:30:00+00:00": 978.8599853515625,
      "2024-05-17T18:30:00+00:00": 978.6599731445312,
      "2024-05-17T19:30:00+00:00": 979.7999877929688
    },
    "sentiment": 0.8732858300209045
  },
  {
    "title": "Regeneron wins temporary restraining order preventing Eylea generic launch (update)",
    "published": 1715908200,
    "day_prices": {
      "2024-05-17T13:30:00+00:00": 969.27001953125,
      "2024-05-17T14:30:00+00:00": 972.8300170898438,
      "2024-05-17T15:30:00+00:00": 976.0499877929688,
      "2024-05-17T16:30:00+00:00": 978.1199951171875,
      "2024-05-17T17:30:00+00:00": 978.8599853515625,
      "2024-05-17T18:30:00+00:00": 978.6599731445312,
      "2024-05-17T19:30:00+00:00": 979.7999877929688
    },
    "sentiment": 0.6379199624061584
  },
  {
    "title": "These 2 No-Brainer Growth Stocks Are Breaking New Ground",
    "published": 1715858100,
    "day_prices": {
      "2024-05-16T13:30:00+00:00": 976.9500122070312,
      "2024-05-16T14:30:00+00:00": 975.6300048828125,
      "2024-05-16T15:30:00+00:00": 977.155029296875,
      "2024-05-16T16:30:00+00:00": 974.75,
      "2024-05-16T17:30:00+00:00": 971.5349731445312,
      "2024-05-16T18:30:00+00:00": 969.6749877929688,
      "2024-05-16T19:30:00+00:00": 968.3250122070312
    },
    "sentiment": 0.7934203743934631
  }
]